Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. In instances where this may seem implied we will do our best to provide sources to any claims as well as links to current studies, clinical trials, and/or research being conducted on the matter.
With the increased consumer interest in cannabis we hope that the current barriers restricting further research are lifted. This would allow public health interests to be addressed with policies reflected to create a more transparent cannabis industry.
We fully support the FDA’s position on unsubstantiated claims regarding the health benefits of CBD. The questions of the untapped therapeutic potential in the cannabis compound must be answered by data and scientific research.
For this reason we understand the existing restrictions in place are to protect consumers and provide guidance to distributers such as ourselves. Healing Dragon CBD looks forward to further research for FDA-approved CBD products.
If you as a consumer would like to research the current studies and clinical trials please visit the links below and search for keywords such as “CBD” and “Cannabidiol”.
ClinicalTrials.gov: ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. ClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine.
Pub Med: PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
The International Cannabinoid Research Society: In addition to acting as a source for impartial information on Cannabis and the cannabinoids, the main role of the ICRS is to provide an open forum for researchers to meet and discuss their research.